Beyond Air, Inc. (XAIR)
NASDAQ (CM) NASDAQ (CM) Primary 
Beyond Air, Inc. (XAIR) Reports Q1 Loss, Misses Revenue Estimates
Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.45 per share a year ago.
All You Need to Know About Beyond Air (XAIR) Rating Upgrade to Strong Buy
Beyond Air (XAIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Beyond Air (XAIR) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Beyond Air (XAIR), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Why Is Beyond Air (XAIR) Stock Down 22% Today?
Beyond Air (NASDAQ: XAIR ) stock is dropping on Tuesday after the commercial-stage medical device and biopharmaceutical company announced its latest earnings results. The bad news for XAIR stock starts with its revenue of $470,000.
Beyond Air, Inc. (XAIR) Reports Q4 Loss, Misses Revenue Estimates
Beyond Air, Inc. (XAIR) came out with a quarterly loss of $0.36 per share versus the Zacks Consensus Estimate of a loss of $0.47. This compares to loss of $0.67 per share a year ago.
Beyond Air, Inc. (XAIR) Q4 2024 Earnings Call Transcript
Beyond Air, Inc. (NASDAQ:XAIR ) Q4 2024 Earnings Call Transcript June 24, 2024 4:30 PM ET Company Participants Garth Russell - Investor Relations, LifeSci Advisors Steve Lisi - Chairman and Chief Executive Officer Douglas Larson - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Yale Jen - Laidlaw & Company Matt Kaplan - Ladenburg Thalmann Operator Good afternoon, and welcome, everyone to the Beyond Air Financial Results Call for the Fiscal Quarter Ended March 31, 2024. At this time, participants are in a listen-only mode.
